Sep 13, 2023 / 05:35PM GMT
Unidentified Analyst
All righty. Thank you very much. It's [Patrick] on the U.S. medtech team here. And very excited to have Jim and Wayde, CEO and CFO of PODD, over here. And it's going to be a really interesting discussion, I think.
Disclosures, morganstanley.com/researchdisclosures, very exciting website. I expect to see all of you there. Reach out to your sales reps if you have any other questions.
And so with that, let's kick it off. I think you want to do some opening remarks, right?
James R. Hollingshead - Insulet Corporation - President, CEO & Director
Yes. Patrick, thank you very much, and thanks, everybody, for joining us today. It's great to have you all here. I'll just start with a couple of comments.
And first one is our business has fantastic momentum. We're coming off of a fantastic Q2 with record new customer starts, record revenue. We grew 32% year-over-year. And it's our fourth straight quarter of growth in the U.S. that starts with a 4. So we've had 4 straight quarters of U.S. growth at 40%-plus, which is really, really
Insulet Corp at Morgan Stanley Global Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers